Innate Pharma S.A - Stock Price History | IPHA

Historical daily share price chart and data for Innate Pharma S.A since 2021 adjusted for splits. The latest closing stock price for Innate Pharma S.A as of October 22, 2021 is 5.59.
  • The all-time high Innate Pharma S.A stock closing price was 8.20 on May 11, 2020.
  • The Innate Pharma S.A 52-week high stock price is 11.95, which is 113.8% above the current share price.
  • The Innate Pharma S.A 52-week low stock price is 3.02, which is 46% below the current share price.
  • The average Innate Pharma S.A stock price for the last 52 weeks is 4.42.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Innate Pharma S.A Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 5.8865 7.3000 8.2000 3.7700 4.0900 -36.49%
2019 6.1483 6.1400 6.5500 5.6600 6.4400 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.443B $0.080B
Innate Pharma S.A. is a commercial stage oncology-focused biotech company. It discovers and develops therapeutic antibodies for the treatment of cancer. The company's commercial-stage product includes Lumoxiti. Innate Pharma S.A. is based in Marseille, France.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76